|
MechanismFree radicals scavengers |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
Originator Org.- |
|
|
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Effects of Quercetin on the Oxidative Stress and Inflammatory Markers in COPD Phase II
This study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease. It is small study with 8 subjects receiving quercetin 1000 mg/day, 8 patients receiving 500 mg/day and 4 subjects receive placebo.
Single-arm Phase 2 Study of Oral Isoquercetin in Sickle Cell Disease
This research study is being done to assess the safety and effectiveness of isoquercetin to reduce levels of soluble P-Selectin in patients with sickle cell disease. Isoquercetin is a naturally occurring flavonoid-or vitamin. You will find quercetin and isoquercetin in fruits and vegetables.
The names of the study drug involved in this study are/is:
- Isoquercetin
Impact of Quercetin on Inflammatory and Oxidative Stress Markers in COPD
This study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease. It is small study with 8 subjects receive quercetin 2000 mg/day and 4 subjects receive placebo.
100 Clinical Results associated with Quercegen Pharmaceuticals LLC
0 Patents (Medical) associated with Quercegen Pharmaceuticals LLC
100 Deals associated with Quercegen Pharmaceuticals LLC
100 Translational Medicine associated with Quercegen Pharmaceuticals LLC